
Trumab 150mg Injection
Marketer
Glenmark Pharmaceuticals Ltd
Salt Composition
Trastuzumab (150mg)
Overview Trumab 150mg Injection
Herceptin-equivalent injection (150mg) treats breast and gastric cancers by targeting and eliminating HER2-positive cells. Administered intravenously by a healthcare professional, dosage and frequency are determined individually by your physician, based on your condition and may vary. Strict adherence to the prescribed regimen is crucial; incorrect usage or overdose can lead to severe complications. Therapeutic effects might not be immediately apparent, potentially taking weeks or months; discontinuation should only occur under medical supervision. Common side effects include nausea, headache, skin rash, sleep disturbances, and increased infection risk. This medication can decrease blood cell counts, raising infection vulnerability, necessitating regular blood tests to monitor blood cell levels, cardiac function, liver health, and uric acid. Report shortness of breath, cough, chills, or limb swelling immediately. Inform your doctor of all other medications you are taking, as interactions are possible. Pregnancy and breastfeeding are contraindicated; effective contraception is essential for both partners throughout treatment.
Primary Ingredients of Trumab 150mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Trumab 150mg Injection
Cancers affecting the breast and stomach
Major Benefits of Trumab 150mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Trumab 150mg Injection:
- Anemia (low number of red blood cells)
- Chills
- Common cold
- Cough
- Decreased blood cells (red cells, white cells, and platelets)
- Diarrhea
- Fatigue
- Fever
- Headache
- Heart failure
- Infection
- Insomnia (difficulty in sleeping)
- Mucosal inflammation
- Nausea
- Rash
- Stomatitis (Inflammation of the mouth)
- Taste change
- Upper respiratory tract infection
- Weight loss
How to use Trumab 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Trumab 150mg Injection works:
The injectable medication Trumab (150mg) is a genetically engineered IgG1 antibody. Its mechanism involves targeting and neutralizing HER2 receptors—proteins that drive excessive growth in breast and gastric cancers. This action directly eliminates cancer cells and concurrently blocks multiple downstream signaling pathways implicated in cancer development.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Trumab 150mg Injection and alcohol can lead to significant somnolence.
PregnancyCONSULT YOUR DOCTOR
Administering 150mg of Trumab via injection is contraindicated during pregnancy due to confirmed risks to fetal development. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the hazards. Physician consultation is essential.
Breast feedingCONSULT YOUR DOCTOR
The administration of Trumab 150mg Injection while breastfeeding is likely inadvisable. Available human data indicates potential transfer to breast milk, posing a possible risk to the infant.
DrivingCONSULT YOUR DOCTOR
The effect of Trumab 150mg Injection on driving ability is unknown. Refrain from driving if experiencing symptoms impairing concentration or reaction time.
KidneySAFE IF PRESCRIBED
The use of 150mg Trumab Injection in patients with kidney impairment appears to pose minimal risk. Preliminary findings indicate dose modification may be unnecessary; however, physician consultation is recommended.
LiverCONSULT YOUR DOCTOR
Data regarding Trumab 150mg Injection use in individuals with hepatic impairment is scarce. Physician consultation is recommended.
What if you forget to take Trumab 150mg Injection :
Should you forget a scheduled Trumab 150mg Injection, seek your physician's advice.
Facts to Know About Trumab 150mg Injection
| Label | Value |
|---|---|
| Chemical Category | Monoclonal antibody |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Actions | Monoclonal antibody HER2/neu (ErbB2) inhibitor |
